AAAAAA

   
Results: 1-4 |
Results: 4
Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey
Authors: Long, J Allwright, S Barry, J Reynolds, SR Thornton, L Bradley, F Parry, JV
Citation: J. Long et al., Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in entrants to Irish prisons: a national cross sectional survey, BR MED J, 323(7323), 2001, pp. 1209-1212
Developing a strategic plan for integrated information resources and services
Authors: Reynolds, SR
Citation: Sr. Reynolds, Developing a strategic plan for integrated information resources and services, ADV LIB ADM, 18, 2001, pp. 45-121
Identification of HLA-A03, A*11 and B*07-restricted melanoma-associated peptides that are immunogenic in vivo by vaccine-induced immune response (VIIR) analysis
Authors: Reynolds, SR Celis, E Sette, A Oratz, R Shapiro, RL Johnston, D Fotino, M Bystryn, JC
Citation: Sr. Reynolds et al., Identification of HLA-A03, A*11 and B*07-restricted melanoma-associated peptides that are immunogenic in vivo by vaccine-induced immune response (VIIR) analysis, J IMMUNOL M, 244(1-2), 2000, pp. 59-67
HLA-independent heterogeneity of CD8(+) T cell responses to MAGE-3, Melan-A/MART-1, gp100, tyrosinase, MC1R, and TRP-2 in vaccine-treated melanoma patients
Authors: Reynolds, SR Celis, E Sette, A Oratz, R Shapiro, RL Johnston, D Fotino, M Bystryn, JC
Citation: Sr. Reynolds et al., HLA-independent heterogeneity of CD8(+) T cell responses to MAGE-3, Melan-A/MART-1, gp100, tyrosinase, MC1R, and TRP-2 in vaccine-treated melanoma patients, J IMMUNOL, 161(12), 1998, pp. 6970-6976
Risultati: 1-4 |